Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults

Toledo-Romani, María Eugenia; García-Carmenate, Mayra; Verdecia-Sánchez, Leslyhana; Pérez-Rodríguez, Suzel; Rodriguez-González, Meybis; Valenzuela-Silva, Carmen; Paredes-Moreno, Beatriz; Sanchez-Ramirez, Belinda; González-Mugica, Raúl; Hernández-Garcia, Tays; Orosa-Vázquez, Ivette; Díaz-Hernández, Marianniz; Pérez-Guevara, María Teresa; Enriquez-Puertas, Juliet; Noa-Romero, Enrique; Palenzuela-Diaz, Ariel; Baro-Roman, Gerardo; Mendoza-Hernández, Ivis; Muñoz, Yaima; Gómez-Maceo, Yanet; Santos-Vega, Bertha Leysi; Fernandez-Castillo, Sonsire; Climent-Ruiz, Yanet; Rodríguez-Noda, Laura; Santana-Mederos, Darielys; García-Vega, Yanelda; Chen, Guang-Wu; Doroud, Delaram; Biglari, Alireza; Boggiano-Ayo, Tammy; Valdés-Balbín, Yury; Rivera, Daniel G.; García-Rivera, Dagmar; Vérez-Bencomo, Vicente; Cubas-Curbelo, Mailin; Rodríguez-Castillo, Pedro Gabriel; Acevedo-Martínez, Yosmel; Estoque-Cabrera, Solangel; Ávila-Cabreja, José Alejandro; Alfaro-Guzmán, Ainadis; Zulueta-Pérez, Lilian; Espino-Rojas, Niurka Tamara; Medinas-Santos, Gloria Margarita; Sarda-Rodriguez, Ileana Luisa; Acosta-Martinez, Mario Alejandro; Reyes-Matienzo, Radamet; Coviella-Artime, José Manuel; Morffi-Cinta, Irania; Martínez-Pérez, Marisel; Valera-Fernández, Rodrigo; Garcés-Hechavarría, Aniurka; Martínez-Bedoya, Dayle; Garrido-Arteaga, Raine; Cardoso-Sanjorge, Félix; Ramírez-Gonzalez, Ubel; Quintero-Moreno, Lauren; Ontivero-Pino, Ivis; Martínez-Rivera, Roselyn; Guillén-Obregón, Berta; Lora-García, Janet; Medina-Nápoles, Maite; Espi-Ávila, Jennifer; Fontanies-Fernández, Marcos; Domínguez-Pentón, Yeney Regla; Bergado-Baez, Gretchen; Pi-Estopiñán, Franciscary; Ojito-Magaz, Eduardo; Rodríguez, Misladys; Cruz-Sui, Otto; García-Montero, Majela; Dubed-Echevarría, Marta; García-López, Elena; Galano-Frutos, Evelyn; Perez-Perez, Alina; Morales-Ruano, Susana; Brito-Pascual, Idalmis; Amoroto, Maité; Arteaga-García, Amaylid

Published in

Cell Press, Med, 11(3), p. 760-773.e5, 2022

DOI: 10.1016/j.medj.2022.08.001

Tools

Export citation

Search in Google Scholar

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults

Journal article published in 2022 by María Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, Suzel Pérez-Rodríguez, Meybis Rodriguez-González, Carmen Valenzuela-Silva, Beatriz Paredes-Moreno, Belinda Sanchez-Ramirez, Raúl González-Mugica, Tays Hernández-Garcia, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María Teresa Pérez-Guevara, Juliet Enriquez-Puertas, Enrique Noa-Romero and other authors.

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults